Desferrioxamine (Desferal)

deferoxamine mesylate · Novartis

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Desferrioxamine (Desferal), covering 2013-11-26 to 2013-11-26. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of Subcutaneous Desferrioxamine as Treatment for Transfusional Hemochromatosis [Phase 2]